| Click here to view the March Issue |
|
![]() |
|
| Click here to view The 2009 Pharma Choice Awards |
|
![]() |
| Anna Stashower President/Publisher Welcome to PM360 |
|
COMMON SENSE By Bud Bilanich |
![]() |
| We All Need Friends |
![]() |
| Special E-Marketing Supplement | |
![]() |
Editor's Letter While the pharma industry faces great challenges, the evolution of the Web and other digital technologies is offering amazing opportunities for brand success. |
![]() |
Influence 3.0™: Social Media Meets Pharmaceutical Communications By Larry Friedman, Ph.D The rapid growth of social media has fundamentally recast how pharmaceutical marketers communicate with consumers online. At the core of this new marketing paradigm: Conversation. |
![]() |
Think Tank: How to Capture Doctors’ “E-ttention” in the Virtual World With so many demands on physicians' time and attention, it’s become increasingly difficult for pharma marketers to make a lasting impression. How can creative E-marketing strategies help representatives reach doctors in new and exciting ways? Here, leaders in the industry offer their insights. |
![]() |
Interview with Craig DeLarge, Associate Director of E-Marketing and Relationship Marketing, Novo Nordisk Inc By Paula Silverman A veteran of E-marketing discusses how the pharmaceutical industry must embrace a new relationship marketing paradigm or risk alienating online customers. |
![]() |
The Metrics of E-Marketing: Deliver the Right Messages for the Right Audience By Dora Shankman Online media advertising by the pharmaceutical and healthcare industry will surpass the $1.3 billion mark by early 2009. With this huge investment also comes accountability. We want performance metrics that are more than just a cost-per-click. How can you ensure that you’re getting the best return on investment on the Web? |